AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Natlawreview

Published November 3, 2026 · Updated November 4, 2026

No Psychedelic Belongs on the Market, Citizens Commission on Huma - The National Law Review

Read the full story at Natlawreview

The watchdog wants psychedelic drug applications rejected. If any drug advances, it says it must be barred for minors, pregnant women,.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics